Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling.
Neuromyelitis Optica Spectrum Disorders.
Orderly Steps in Progression of JC Virus to Virulence in the Brain.
Multiple sclerosis: Dimethyl fumarate is coming of age.
Gray Matter Segmentation of the Spinal Cord with Active Contours in MR Images.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.
A multi-biomarker follow-up study of patients with multiple sclerosis.
Axonopathy in the Central Nervous System Is the Hallmark of Mice with a Novel Intragenic Null Mutation of Dystonin.
Herpes zoster laryngitis in a patient treated with fingolimod.
Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis.
mRNA expression profile of mouse oligodendrocytes in inflammatory conditions.
The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Conditional Deletion of the L-Type Calcium Channel Cav1.2 in Oligodendrocyte Progenitor Cells Affects Postnatal Myelination in Mice.
Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology.
Effects of a home-based upper-limb training program in patients with Multiple Sclerosis: a randomized controlled trial.
Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson's disease.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis.
An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0.
MRI in the evaluation of pediatric multiple sclerosis.
Pages
« first
‹ previous
…
770
771
772
773
774
775
776
777
778
…
next ›
last »